Porcine Vaccines Market - By Vaccine Type: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Subunit Vaccines; By Disease Type: Porcine Reproductive and Respiratory Syndrome (PRRS), Swine Influenza, Porcine Circovirus, Aujeszky's Disease, Others; By End User: Veterinary Hospitals, Veterinary Clinics, Swine Farms, Others; By Region: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
8.6 Global Porcine Vaccines Market - Opportunity Analysis Index,
By Vaccine Type,
By Disease Type,
By End User,
and Region, 2024 - 2031
9. North America Global Porcine Vaccines Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
9.1 By Vaccine Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
9.1.1 Inactivated Vaccines
9.1.2 Live Attenuated Vaccines
9.1.3 Recombinant Vaccines
9.1.4 Subunit Vaccines
9.2 By Disease Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
9.2.1 Porcine Reproductive and Respiratory Syndrome (PRRS)
9.2.2 Swine Influenza
9.2.3 Porcine Circovirus
9.2.4 Aujeszky's Disease
9.2.5 Others
9.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
9.3.1 Veterinary Hospitals
9.3.2 Veterinary Clinics
9.3.3 Swine Farms
9.3.4 Others
9.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
9.4.1 United States
9.4.2 Canada
9.5 North America
Global Porcine Vaccines Market – Opportunity Analysis Index,
By Vaccine Type,
By Disease Type,
By End User,
and Country, 2024 - 2031
9.6 Regional Trends Analysis
9.7 North America Global Porcine Vaccines Market Research Report - Company Profiles
9.7.1 Company 1 (United States)
9.7.2 Company 2 (Canada)
9.7.3 Company 3 (Canada)
10. Europe Global Porcine Vaccines Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
10.1 By Vaccine Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
10.1.1 Inactivated Vaccines
10.1.2 Live Attenuated Vaccines
10.1.3 Recombinant Vaccines
10.1.4 Subunit Vaccines
10.2 By Disease Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
10.2.1 Porcine Reproductive and Respiratory Syndrome (PRRS)
10.2.2 Swine Influenza
10.2.3 Porcine Circovirus
10.2.4 Aujeszky's Disease
10.2.5 Others
10.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
10.3.1 Veterinary Hospitals
10.3.2 Veterinary Clinics
10.3.3 Swine Farms
10.3.4 Others
10.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
10.4.1 Germany
10.4.2 United Kingdom
10.4.3 France
10.4.4 Spain
10.4.5 Italy
10.4.6 Russia
10.4.7 Netherlands
10.4.8 Poland
10.4.9 Rest of Europe
10.5 Europe
Global Porcine Vaccines Market – Opportunity Analysis Index,
By Vaccine Type,
By Disease Type,
By End User,
and Country, 2024 - 2031
10.6 Regional Trends Analysis
10.7 Europe Global Porcine Vaccines Market Research Report - Company Profiles
10.7.1 Company 1 (Germany)
10.7.2 Company 2 (United Kingdom)
10.7.3 Company 3 (United Kingdom)
11. Asia-Pacific Global Porcine Vaccines Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
11.1 By Vaccine Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
11.1.1 Inactivated Vaccines
11.1.2 Live Attenuated Vaccines
11.1.3 Recombinant Vaccines
11.1.4 Subunit Vaccines
11.2 By Disease Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
11.2.1 Porcine Reproductive and Respiratory Syndrome (PRRS)
11.2.2 Swine Influenza
11.2.3 Porcine Circovirus
11.2.4 Aujeszky's Disease
11.2.5 Others
11.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
11.3.1 Veterinary Hospitals
11.3.2 Veterinary Clinics
11.3.3 Swine Farms
11.3.4 Others
11.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Australia & NZ
11.4.6 ASEAN
11.4.7 Rest of Asia-Pacific
11.5 Asia-Pacific
Global Porcine Vaccines Market – Opportunity Analysis Index,
By Vaccine Type,
By Disease Type,
By End User,
and Country, 2024 - 2031
11.6 Regional Trends Analysis
11.7 Asia-Pacific Global Porcine Vaccines Market Research Report - Company Profiles
11.7.1 Company 1 (China)
11.7.2 Company 2 (Japan)
11.7.3 Company 3 (Japan)
12. Latin America Global Porcine Vaccines Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
12.1 By Vaccine Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
12.1.1 Inactivated Vaccines
12.1.2 Live Attenuated Vaccines
12.1.3 Recombinant Vaccines
12.1.4 Subunit Vaccines
12.2 By Disease Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
12.2.1 Porcine Reproductive and Respiratory Syndrome (PRRS)
12.2.2 Swine Influenza
12.2.3 Porcine Circovirus
12.2.4 Aujeszky's Disease
12.2.5 Others
12.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
12.3.1 Veterinary Hospitals
12.3.2 Veterinary Clinics
12.3.3 Swine Farms
12.3.4 Others
12.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
12.4.1 Brazil
12.4.2 Mexico
12.4.3 Argentina
12.4.4 Peru
12.4.5 Colombia
12.4.6 Rest of Latin America
12.5 Latin America
Global Porcine Vaccines Market – Opportunity Analysis Index,
By Vaccine Type,
By Disease Type,
By End User,
and Country, 2024 - 2031
12.6 Regional Trends Analysis
12.7 Latin America Global Porcine Vaccines Market Research Report - Company Profiles
12.7.1 Company 1 (Brazil)
12.7.2 Company 2 (Mexico)
12.7.3 Company 3 (Mexico)
13. Middle East & Africa Global Porcine Vaccines Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
13.1 By Vaccine Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
13.1.1 Inactivated Vaccines
13.1.2 Live Attenuated Vaccines
13.1.3 Recombinant Vaccines
13.1.4 Subunit Vaccines
13.2 By Disease Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
13.2.1 Porcine Reproductive and Respiratory Syndrome (PRRS)
13.2.2 Swine Influenza
13.2.3 Porcine Circovirus
13.2.4 Aujeszky's Disease
13.2.5 Others
13.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
13.3.1 Veterinary Hospitals
13.3.2 Veterinary Clinics
13.3.3 Swine Farms
13.3.4 Others
13.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
13.4.1 Saudi Arabia
13.4.2 UAE
13.4.3 South Africa
13.4.4 Egypt
13.4.5 Israel
13.4.6 Rest of Middle East and Africa
13.5 Middle East & Africa
Global Porcine Vaccines Market – Opportunity Analysis Index,
By Vaccine Type,
By Disease Type,
By End User,
and Country, 2024 - 2031
13.6 Regional Trends Analysis
13.7 Middle East & Africa Global Porcine Vaccines Market Research Report - Company Profiles
13.7.1 Company 1 (Saudi Arabia)
13.7.2 Company 2 (UAE)
13.7.3 Company 3 (UAE)
14. Competition Landscape
14.1 Strategic Dashboard of Top Market Players
14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
14.2.1 Zoetis
14.2.2 Merck Animal Health
14.2.3 Ceva Santé Animale
14.2.4 Boehringer Ingelheim
14.2.5 Elanco
14.2.6 Phibro Animal Health
14.2.7 Virbac
14.2.8 HIPRA
14.2.9 Biogénesis Bagó
14.2.10 Bioveta
15. Data Collection Method and Research Approach 16. Principal Presumptions and Acronyms
Methodology & Credibility
Built for enterprise decisions, not vanity metrics.
Triangulated Sizing
Bottom-up, top-down, and peer benchmarks reconciled by analysts.
Primary + Secondary Research
Executive interviews combined with validated public and paid sources.
Scenario & Sensitivity
Base, bull and bear cases to stress-test strategic moves.
Need Confidence Fast?
We’ll map your questions to the report in 15 minutes.